Three scientists win 2026 Nobel Prize for optogenetics breakthrough

Three pioneering scientists have been honoured with the 2026 Nobel Prize in Physiology or Medicine for their groundbreaking work in optogenetics, a revolutionary technique that enables precise control of nerve cell activity through light stimulation.

The recipients were recognised by the Nobel Assembly for discoveries that fundamentally changed how neuroscientists study the brain. By combining genetics and optics, the researchers developed methods to activate or silence individual neurons in living organisms, providing unprecedented insight into neural circuits and brain function.

Optogenetics has become an essential tool in neuroscience research across laboratories worldwide. The technique involves introducing light-sensitive proteins into specific nerve cells, allowing researchers to control their activity with remarkable precision by directing light at targeted brain regions. This capability has enabled scientists to trace how neural circuits function and to understand the mechanisms underlying various neurological conditions.

The breakthrough has far-reaching implications for neuroscience and medicine. Researchers are now exploring how optogenetic approaches might eventually lead to new therapeutic strategies for neurological and psychiatric disorders, from Parkinson's disease to depression and epilepsy. The award underscores the significance of fundamental discoveries that open entirely new avenues for understanding and potentially treating brain disorders.

The Nobel Prize recognition is expected to further accelerate research into optogenetics applications, particularly in studying how specific neural circuits contribute to behaviour, sensation, and cognition. Scientists in India and across South Asia are among those utilising these techniques to advance understanding of brain function and disease mechanisms.